Detailed instructions for the usage and dosage of tilsiparatide/tilpotide

Tirzepatide is a dual GIP/GLP-1 receptor agonist injected subcutaneously once a week and is widely used in type 2 diabetes control and chronic weight management. Its usage and dosage vary slightly due to different treatment purposes, but generally a gradual increase is adopted to improve the efficacy and reduce gastrointestinal adverse reactions.

For patients with type 2 diabetesthe starting dose is usually 2.5 mg each time, subcutaneously injected once a week. After 4 weeks of continuous use, it is recommended to increase the dose to 5 mg/week as a maintenance dose. If blood sugar control is still unsatisfactory, after using the current dose for at least 4 weeks, the dose can be gradually increased by 2.5 mg each time based on individual tolerance and control needs. The maximum recommended dose is 15mg per week. The entire dosage adjustment process must be carried out under the guidance of a doctor to ensure efficacy and safety.

In terms of chronic weight management, the dose adjustment path for tilsiparatide is similar to that for diabetes. Also start from 2.5mg/week, and increase to 5mg/week after 4 weeks. If the weight loss effect is not satisfactory, you can continue to increase the dosage by 2.5mg every 4 weeks on the basis of 5mg, and gradually adjust to a maximum of 15mg/week. Studies have shown that gradually increasing the dose can significantly reduce patients' gastrointestinal discomforts such as nausea and vomiting, thereby improving compliance and long-term medication tolerance.

The injection site of tilsiparatide can be selected on the abdomen, thigh or upper arm, and the injection time should be fixed at the same time every week. If a dose is missed due to special circumstances, as long as the next injection is more than 72 hours away, the original dose can still be taken as soon as possible; if it is less than 72 hours, the current dose should be skipped and the next injection should be continued according to the original plan. Overall, tilsiparatide is easy to use, safe and suitable for long-term regular use. It needs to be combined with blood sugar monitoring and weight assessment, and the dose should be gradually optimized under the guidance of a doctor to achieve the best therapeutic effect.

Reference materials:https://www.drugs.com/tirzepatide.html